ライフサイエンスコーパス: before administration

1 soluble oral drugs by drinking COS solution before administration.

2 e with drug pumps and require reconstitution before administration.

3 OTACs with E3Ps (called "pre-fused PROTACs") before administration could transform the original PROTA

4 reason compared with 16 602 in the 3 months before administration (decrease of 36.1%, 95% CI 34.7-37

5 Before administration, Gammaproteobacteria and Bacilli d

6 injected intravenously with trastuzumab 24 h before administration of ((111)In-DTPA)(n)-trastuzumab-(

7 ents, unlabeled free folic acid was injected before administration of (111)In-DTPA-folate to also ass

8 venous glucose loading and insulin injection before administration of (18)F-FDG for PET myocardial vi

9 Unenhanced images were obtained before administration of 120 mL of an intravenous contra

10 mg/kg intravenously) over the 45-min period before administration of 18F-FCWAY almost obliterated de

11 ed the prevalence of pre-bronchodilator (ie, before administration of 200 mug salbutamol) and post-br

12 njection of 100 ng CX3CL1/fractalkine 30 min before administration of 400 ng DAMGO, 100 ng DPDPE or 2

13 tissues of mice that received 2 mg/kg of EU before administration of 5-FU.

14 Antibody concentrations were low before administration of a booster dose with detectable

15 ly in the third and fourth weeks immediately before administration of a second dose.

16 bronchoprotective effect, DIs were performed before administration of a single dose of methacholine,

17 ) or dextran sulfate (10 mg/kg, iv) 24 hours before administration of acetaminophen (300 mg/kg).

18 or maximal effectiveness, could be initiated before administration of adjuvant therapies.

19 val in the emergency department to high risk before administration of antibiotics.

20 ells/mm3; placebo recipients, 657 cells/mm3) before administration of antiretroviral therapy (ART) an

21 Administration of VPA before administration of APAP increased the severity of

22 Before administration of aspirin, all subjects underwent

23 unction as demonstrated by 2D echocardiogram before administration of AVP.

24 mmittee on Cancer stage IV melanoma patients before administration of biochemotherapy.

25 ients to receive mTOR/IRS pathway inhibitors before administration of chemotherapy.

26 Before administration of cisapride, four of the 12 patie

27 rritin measured within 72 h of diagnosis and before administration of corticosteroids or other anti-i

28 CTH were diagnostic for Cushing disease (> 2 before administration of CRH and > 3 after administratio

29 sponders had higher diversity of microbiomes before administration of donor material than fecal sampl

30 Such treatment given immediately before administration of Doxil, a liposomally encapsulat

31 In these same studies, before administration of DPCPX, or ZM 241385, hypoxia ha

32 s, such cytokine levels returned to baseline before administration of DSS.

33 Just before administration of each test dose, blood was drawn

34 f COX-2 before administration of OA alone or before administration of Etx and OA did not have any sig

35 ear cells obtained from the peripheral blood before administration of G-CSF (preG-PBMC).

36 peripheral blood mononuclear cells obtained before administration of G-CSF (preG-PBMCs).

37 Nonmyeloablative busulfan conditioning before administration of gene corrected autologous hemat

38 Presence of grade 4 toxicity before administration of glucarpidase, inadequate initia

39 otherapy strategy was used to debulk disease before administration of granulocyte colony-stimulating

40 mbers of circulating B and activated T cells before administration of HgCl2, and less autoreactivity

41 ppearance (active control group) about 1-2 h before administration of highly emetogenic chemotherapy.

42 ily CsA (10 mg/kg) by oral gavage for 4 days before administration of IT LEW cells and ALS.

43 nti-murine MIP-2 serum intraperitoneally 2 h before administration of K. pneumoniae.

44 Before administration of L-NMMA in the brachial artery,

45 istered neutralizing antibodies to TNF-alpha before administration of low, but hepatotoxic, doses of

46 ine (6 mg/kg, intraperitoneally) immediately before administration of LPS (0.83 mg/kg, intraperitonea

47 Treatment of monocytes with estradiol before administration of LPS reduces CXCL8 message and p

48 Before administration of MMR2 in the kindergarten group,

49 l in appearance (active control group) 1-2 h before administration of moderately emetogenic chemother

50 luteal phase of the menstrual cycle, 40 min before administration of NMDA (10 mg/kg b.wt., i.v.).

51 Inhibition of COX-2 before administration of OA alone or before administrati

52 he third ventricle via an indwelling cannula before administration of peripheral LiCl.

53 el that demonstrates reduced kidney function before administration of radiocontrast media (RCM).

54 a, FI, and postprandial abdominal discomfort before administration of SBI.

55 transit, and colonic transit were determined before administration of study drug and after 1 week on

56 Activation of NF-kappaB with TNFalpha before administration of temozolomide reduces the cytoto

57 A tropism test is required before administration of the antiretroviral drug maravir

58 vealed that binding of bacteria to E was <1% before administration of the bispecific reagent, but wit

59 nts were performed in which HO was inhibited before administration of the CO donors.

60 he patient reported had a normal QT interval before administration of the drug.

61 nd 3 were tested on serum specimens obtained before administration of the first dose of IPV and 28-45

62 r viral load, which was assessed immediately before administration of the first dose through the 12th

63 ns because many patients had transplantation before administration of the intervention.

64 agonist salvinorin A (0.01-1.8 mg/kg, i.v.) before administration of the KOR selective radiotracer [

65 Before administration of the placebo or phylloquinone, t

66 de were performed in 11 normal male subjects before administration of the serotonin-releasing agent a

67 ing scale pain scores measured from the time before administration of the study drug to 30 minutes la

68 was performed within 5 days of the STEMI and before administration of the study drug.

69 w that, if resistant populations are present before administration of therapy, treatments designed to

70 BP1s+ ILC3s in patients with Crohn's disease before administration of ustekinumab, an anti-IL-12/IL-2

71 rhage but fell from 319+/-66 to 29+/-9 pg/mL before administration of vasopressin (P<0.01).

72 norphine taper followed by a week-long delay before administration of XR-naltrexone, consistent with

73 loyed to achieve near-100% pure gas-phase Xe before administration to the sample or subject.

74 pooledhIgG, or mixing pooledhIgG with SScIgG before administration to tissues, significantly reduced

75 the effectiveness of individual preparations before administration, to ensure effective treatment.

76 Before administration with the cycloplegia treatment 1 %